MABGALAXY

MABGALAXY is a biotechnology company focused on the research and development of innovative antibody drugs, with locations in Beijing, China, and Cambridge, UK. The company is committed to developing next-generation antibody therapies for the treatment of inflammatory and autoimmune diseases. By combining its proprietary antibody platform technology with intelligent R&D capabilities, MABGALAXY continues to advance the development of new antibody drugs to expand the therapeutic window, overcome drug resistance mechanisms, and explore new therapeutic targets. With a robust drug discovery engine and an experienced R&D team, MABGALAXY is continuously building a pipeline of antibody drugs with clinically differentiated potential, aiming to deliver tangible clinical benefits to patients with significant unmet medical needs.